Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2003
08/28/2003WO2003070166A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003WO2003028641A3 Mch receptor antagonists
08/28/2003WO2003002559A3 Piperidine compounds for use as orexin receptor antagonist
08/28/2003WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha
08/28/2003WO2002000638A8 Substituted phthalides as anti-convulsive drugs
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162960 Compounds containing pyrroles as the key recognition element and a quinoxaline backbone as part of the compound for use in system with a built-in optical probe for selective sensing
08/28/2003US20030162806 Nitrogen compounds such as N-(4-(4- Amino-2-butyl-6,7-dimethyl -1H-imidazo(4,5-c)pyridin-1-yl)butyl)benzamide, used as immunomodulators, for inducing cytokine biosynthesis, and for prophylaxis of viral diseases
08/28/2003US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders
08/28/2003US20030162800 Nitrogen compounds such as 10-Butyl-8-chloro-10-(trifluoro methyl)-5,10-dihydropyrimido(5,4-b)quinolin-4(3H)-one, used as polymerase inhibitors for prophylaxis of viral diseases
08/28/2003US20030162799 Squaric acid derivatives
08/28/2003US20030162791 Phenylpiperazines
08/28/2003US20030162785 1,3-dihydro-2H-indol- 2-one derivatives
08/28/2003US20030162784 Pyridazinone aldose reductase inhibitors
08/28/2003US20030162783 Method and composition for the treatment of pain
08/28/2003US20030162777 Administering a biheterocyclic compounds containing aminocarbonyl, aminothiocarbonyl or aminosulfonyl group for treating neuromuscular dysfunction of the lower urinary tract in a mammal in need of such treatment
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003US20030162759 Preventing or treating cardiovascular disease including atherosclerosis
08/28/2003CA2476822A1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003CA2476665A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003CA2476624A1 Azabicyclic compounds for the treatment of disease
08/28/2003CA2476417A1 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003CA2476406A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003CA2474848A1 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/27/2003EP1338337A2 Catalysts and methods for catalytic oxidation
08/27/2003EP1337534A1 3-substituted 2,7-naphthyridin-1-yl derivatives
08/27/2003EP1337533A2 Resolution of trans-7-(hydroxy-methyl)octa-hydro-2h-pyrido-1,2a)pyrazine
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337523A2 2,4-substituted pyridine derivatives
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
08/27/2003EP1337252A2 Methods of use of fluoroquinolone compounds against pathogenic helicobacter bacteria
08/27/2003EP1178042B1 Beta-diketonato-metal complexes and process for the preparation thereof, photoelectric conversion devices and photoelectrochemical cells
08/27/2003EP1165547B1 Substituted benzoylpyrazoles as herbicides
08/27/2003EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors
08/27/2003EP0968211B1 Tetrazole derivatives
08/27/2003EP0946567B1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003CN1439008A 1-(heteroaryl-henyl)-condensed pyrazol derivatives as factor XA inhibitors
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1439002A Muscarinic agonists
08/27/2003CN1439001A Tetrahydropyridino or piperidino hetlrocyclic derivatives
08/27/2003CN1438220A 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
08/27/2003CN1119347C Process of preparing matrine from foxtail-like sophora seed
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/26/2003US6610849 Process for the manufacture of tropenol
08/26/2003US6610731 Antiinflammatory
08/26/2003US6610708 Cyclic amino compounds
08/26/2003US6610701 For therapy and prophylaxis of blood coagulation and cardiovascular disorders
08/26/2003US6610700 Inhibit binding of integrins to their ligands, use in immune or inflammatory disorders; 3-(4-((2,6-Naphthyridinyl)amino)-phenyl)-2-((2-(1-ethylpropyl)-3-oxo-1 -cyclopentenyl) amino)-propionic acid, for example
08/26/2003US6610692 Anticoagulants
08/26/2003US6610688 For therapy of blood vessel proliferative disorders; fibrotic disorders; mesangial cell proliferative disorders; metabolic disorders; allergies; asthma; thrombosis; nervous system diseases; and cancer
08/26/2003US6610684 Fused azepinone cyclin dependent kinase inhibitors
08/26/2003US6610677 Enhancing glycogen synthesis, lowering blood levels of glucose, treating colon, ovarian, or breast cancer, treating diabetes, treating schizophrenia
08/26/2003US6610327 Oral administration which comprises moxifloxacin, its salt and/or hydrate and lactose, to a process for its preparation, and to the use of this preparation for controlling bacterial infections in humans and animals.
08/26/2003US6610319 Immune response modifier compounds for treatment of TH2 mediated and related diseases
08/26/2003CA2092211C Imidazole compounds, their preparation and use
08/21/2003WO2003069303A2 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof
08/21/2003WO2003068774A1 Tricyclic n-acyl compounds
08/21/2003WO2003068773A1 Pyrazolopyridine derivatives
08/21/2003WO2003068769A1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
08/21/2003WO2003068767A1 Pyrimidines as novel openers of potassium ion channels
08/21/2003WO2003068756A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)]-6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068221A1 Indole, azaindole and related heterocyclic pyrrolidine derivatives
08/21/2003WO2003068148A2 Treatment of sleep disorders using sleep target modulators
08/21/2003WO2003024935A3 Substituted pyrazolyl compounds for the treatment of inflammation
08/21/2003WO2003001887A3 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
08/21/2003WO2002046158A3 Piperidine/piperazine-type inhibitors of p38 kinase
08/21/2003US20030158418 Novel imidazonline compounds
08/21/2003US20030158414 Process for preparing growth hormone secretagogues
08/21/2003US20030158413 A thiochromane-7-carboxamide derivatives as Rho kinase enzyme inhibitor; nontoxic, anticancer agents
08/21/2003US20030158409 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
08/21/2003US20030158256 (Arylaminoaceamido)acetonitrile derivatives
08/21/2003US20030158225 Novel compounds
08/21/2003US20030158224 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents
08/21/2003US20030158222 2-3-dihydro-1H-isoindole derivatives useful as modulators of dopamine D3 receptors (an-tipsychotic agents)
08/21/2003US20030158221 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome.
08/21/2003US20030158219 N-substituted spiropiperidine compounds as ligands for ORL-1 receptor
08/21/2003US20030158218 Amino-substituted N-(arylalkyl)amidomethyl- pyridine or pyrimidine derivative or its N-oxide
08/21/2003US20030158216 2-acyl indole derivatives and their use as antitumor agents
08/21/2003US20030158208 Dopamine D4 ligands for the treatment of novelty-seeking disorders
08/21/2003US20030158202 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
08/21/2003US20030158197 Certain alkylene diamine-substituted heterocycles
08/21/2003US20030158195 1,6 naphthyridines useful as inhibitors of SYK kinase
08/21/2003US20030158193 Therapeutic treatment of gastrointestinal inflammatory disorders, ulcer disorders
08/21/2003US20030158192 Activating cytokine biosynthesis, viricides treating a viral disease, antitumor agents, immunomodulators
08/21/2003US20030158173 NK 1 antagonists
08/21/2003US20030158105 Determining polypeptide sequence of at least one Bcr-Abl polypeptide expressed by the human cancer cell and comparing the polypeptide sequence of the Bcr-Abl polypeptide expressed by the human cancer cell to the Bcr-Abl polypeptide sequence
08/21/2003US20030157180 Suitable as depot formulation for administration via intramuscular or subcutaneous injection
08/21/2003CA2476024A1 Pyrimidines as novel openers of potassium ion channels
08/21/2003CA2475825A1 Tricyclic n-acyl compounds
08/21/2003CA2474195A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)]-6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
08/21/2003CA2473586A1 Treatment of sleep disorders using sleep target modulators
08/21/2003CA2472822A1 Chemical compounds
08/20/2003EP1336611A1 Dehalogeno compounds
08/20/2003EP1335923A2 Condensed pyridoindole derivatives
08/20/2003EP1335917A2 Condensed pyridoindole derivatives
08/20/2003EP1335916A1 Pyridyl-substituted triazoles as tgf inhibitors
1 ... 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 ... 646